6,927
Participants
Start Date
July 31, 2005
Primary Completion Date
November 30, 2016
Study Completion Date
December 13, 2021
Permanent iodine-125 (Brachytherapy)
Observational research was conducted by grouping Brachytherapy with/without PI (permanent iodine) seed implantation.
Fujita Health University, Toyoake
Shikoku Cancer Center, Matsuyama
Ehime University Hospital, Tōon
Isesaki Municipal Hospital, Isesaki
Gunma University Graduate School of Medicine, Maebashi
Kurosawa Hospital, Takasaki
Sapporo Medical University, Sapporo
Translational Research Informatics Center, Kobe
Ibaraki Prefectural Central Hospital, Kasama
Kagawa University Hospital, Hiragi
Osaka University Graduate School of Medicine, Suita
National Hospital Organization - Saitama National Hospital, Wako
Shiga University of Medical Science, Ōtsu
Shimane University Hospital, Izumo
University of Fukui Hospital, Fukui
Hamanomachi Hospital, Fukuoka
Kyushu University Hospital, Fukuoka
Gifu University Graduate School of Medicine, Gifu
Gunma Cancer Center, Gunma
Kitasato University School of Medicine, Kanagawa
Kyoto Prefectural University of Medicine, Kyoto
Nagasaki University Hospital, Nagasaki
Okayama University Medical School, Okayama
Saitama Cancer Center, Saitama
Tokushima University Hospital, Tokushima
Nippon Medical School, Tokyo
University of Tokyo Hospital, Tokyo
Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo
National Hospital Organization - Tokyo Medical Center, Tokyo
Keio University School of Medicine, Tokyo
Tokyo Women's Medical University, Tokyo
Kurosawa Hospital
UNKNOWN
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
OTHER